The Future of Long COVID

CHF 58.35
Auf Lager
SKU
8JMKT8PIL7C
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

This book provides an overview of Long COVID, the chronic illness and disability that can result from COVID-19 infection in 2030% of survivors. It approaches the topic through its larger social, political, and historical context utilizing the Threatcasting methodology for scenario-based foresight. The book brings together multiple perspectives on Long COVID, such as patient experiences, healthcare system impacts, historical frameworks, and the information ecosystem surrounding COVID to explore the long-term structural implications of Long COVID beyond the current acute crisis. It is intended to be a guide for policy makers, healthcare providers, researchers, and anyone whose work will play a role in mitigating the long tail of COVID-19. Framing the pandemic within a historical and political framework while approaching Long COVID from the future-casting perspective, this book seeks to disentangle the issues posed by Long COVID from the current moment and is intended to establish newways of thinking about and preparing for similar complex, over-the-horizon potential threats. The first book to apply the Threatcasting framework to a public-health issue like COVID-19Draws together multiple perspectives of Long COVID that were previously discussed independently within their fieldsComprehensively examines the history and future of Long COVID

The first book to apply the Threatcasting framework to a public-health issue like COVID-19 Draws together multiple perspectives of Long COVID that were previously discussed independently within their fields Comprehensively examines the history and future of Long COVID

Autorentext

Melissa Smallwood (M.S. 2021, M.A. 2016) is a Science and Technology Policy researcher with a background in neuroscience, psychology, social science, and disability studies. She is interested in how disability and healthcare justice issues intersect with emerging technologies, political trends, and dominant paradigms in medicine and academia. Prior to the global disruption of the COVID-19 pandemic, Smallwood was interested in the tensions between patient advocate groups and the medical establishment-a subject with which many more people are now being forced to grapple. Smallwood was introduced to the Threatcasting methodology through Brian David Johnson's lab at Arizona State University, where she worked with a group to forecast a range of potential outcomes of COVID-19 and to apply the lessons of the pandemic to anticipatory policy-making moving forward. She decided to use this approach to specifically look at Long COVID-an under-reported public health issue with massive societal implications. The findings of this project form the basis for Smallwood's debut book, The Future of Long COVID. Smallwood currently works with software that supports the development of emerging technologies, as well as being an independent researcher and activist focused on Long COVID, COVID mitigation, and other justice issues highlighted by the COVID-19 pandemic.


Inhalt

Introduction.- What is Long COVID?.- International Perspectives on Long COVID.- COVID-19 vs. Past Pandemics: What Can we Learn? .- Threatcasting Project & Themes.- Where Do We Go from Here? .- Conclusion.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783031404764
    • Sprache Englisch
    • Größe H240mm x B168mm x T7mm
    • Jahr 2024
    • EAN 9783031404764
    • Format Kartonierter Einband
    • ISBN 3031404769
    • Veröffentlichung 13.09.2024
    • Titel The Future of Long COVID
    • Autor Melissa Smallwood
    • Untertitel A Threatcasting Approach
    • Gewicht 210g
    • Herausgeber Springer
    • Anzahl Seiten 116
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470